Position in LH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,847,240
+$218,350 QoQ
Shares Held
20,883
-1.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#227
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GREAT LAKES ADVISORS, LLC holds $122,300,093 across 9 Diagnostics & Research names. LH ranks #2 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
214,974 | $107,779,362 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
20,883 | $5,847,240 | |
| 3 | VCYT |
Veracyte, Inc.
|
65,579 | $3,851,454 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,991 | $2,101,021 | |
| 5 | DHR |
Danaher Corp /De/
|
7,498 | $1,428,218 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
2,026 | $459,476 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,234 | $296,742 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,455 | $281,135 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,847,240 | 20,883 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,628,890 | 21,097 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,583,836 | 22,257 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,771,745 | 23,590 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,376,630 | 24,291 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,956,282 | 25,592 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $6,200,354 | 27,038 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $779,498 | 3,488 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $715,948 | 3,518 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||